# Sionna Therapeutics (SION) — Earnings

SION · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sion/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2024 |
| Period end | Dec 31, 2024 |
| EPS actual | −$3.38 |
| EPS estimate | −$1.28 |
| EPS surprise | −164.75% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Mar 20, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/2036042/000119312525058306/d679677d8k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2024 | Mar 20, 2025 | −$1.28 | −$3.38 | -164.75% | — | — |

## Frequently Asked Questions

### When did Sionna Therapeutics (SION) last report earnings?

Sionna Therapeutics last reported on Mar 20, 2025, covering fiscal Q4 2024.

### Did SION beat earnings estimates?

No. Sionna Therapeutics reported EPS of −$3.38 for Q4 2024 against a −$1.28 estimate — a 164.75% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).